Latest News
Eos Energy Shares Surge on German Battery Storage Deal
Eos Energy shares rose 11.7% after announcing a binding supply pact with CAPAC Energy for up to 2 GWh of battery storage through 2031, following the start of commercial production at a second manufacturing line.
NuScale Power Rises 3.9% on Paragon Reactor Safety Contract
NuScale Power shares rose 3.9% after awarding Paragon a contract to complete final design work on key protection systems for its small modular reactor technology.
Citi Bullish on Figma: AI Monetization Strategy Solid, $36 Target Set
Citi initiates Figma at Buy with a $36 target, citing strong AI monetization. Shares rise premarket after a 52% YTD decline.
Lionsgate Shares Slip After Netflix Denies Acquisition Interest
Lionsgate shares dropped 5.6% premarket after Netflix denied takeover interest, ending a rally that saw the stock surge nearly 14% on Tuesday.
Ondas Unveils Autonomous Defense Lineup; Stock Slips on Resale Filing
Ondas closed down 3.15% at $9.21 after launching new autonomous defense systems at Eurosatory 2026, while a resale filing for 6.07M shares raises near-term overhang concerns.
G7 Leaders Debate AI Model Access Amid OpenAI's $1T IPO Plan and Rising China Competition
G7 leaders debate AI model access as OpenAI files for a $1T IPO. Anthropic restricts models, China boosts local AI, and cybersecurity deals surge.
Nu Holdings Steady After Citi Downgrade, Credit Concerns Loom
Nu Holdings closed flat after Citigroup downgraded the stock to neutral, citing credit losses and margin pressure. A $1B buyback and strong Q1 earnings provide support.
Amazon Leo, AST SpaceMobile, and China Launches: June 2026 Space and Satellite News
Arianespace's Ariane 6 launched 36 Amazon Leo satellites, AST SpaceMobile deployed three direct-to-phone satellites, and China launched Shijian-31, highlighting the competitive satellite broadband landscape.
FDA Greenlights uniQure's Accelerated Approval Path for Huntington's Gene Therapy
uniQure shares surged 78% premarket after the FDA agreed to accept three-year Phase I/II data as the basis for an accelerated approval filing for AMT-130 in Huntington's disease, reviving the near-term U.S. path for the potential first disease-modifying treatment.
CarMax Revenue Beat Fails to Ease Margin Concerns
CarMax beat Q1 revenue estimates at $8.01B, but retail gross profit per unit dropped to $2,177, highlighting ongoing margin pressure. Shares rose 5% premarket before settling near $52.11.
Lunai Bioworks Shares Surge on Nasdaq Compliance Filing
Lunai Bioworks shares surged 80.88% after hours to $5.15 after Nasdaq confirmed compliance with the $1 minimum bid-price rule, averting delisting risk, though the company remains under a one-year panel monitor and has expressed substantial doubt about its ability to continue operations.